Eagle Veterinary Technology Co.Ltd
Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, … Read more
Eagle Veterinary Technology Co.Ltd - Asset Resilience Ratio
Eagle Veterinary Technology Co.Ltd (044960) has an Asset Resilience Ratio of 6.31% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Eagle Veterinary Technology Co.Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Eagle Veterinary Technology Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.84 Billion | 6.31% |
| Total Liquid Assets | ₩3.84 Billion | 6.31% |
Asset Resilience Insights
- Limited Liquidity: Eagle Veterinary Technology Co.Ltd maintains only 6.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Eagle Veterinary Technology Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Eagle Veterinary Technology Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620 |
Pharmaceuticals | 4.28% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Sam-A Pharm. Co. Ltd
KQ:009300 |
Pharmaceuticals | 34.37% |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040 |
Pharmaceuticals | 5.22% |
|
WooGene B&G Co. Ltd
KQ:018620 |
Pharmaceuticals | 3.35% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
|
EstechPharma Co. Ltd
KQ:041910 |
Pharmaceuticals | 9.64% |
Annual Asset Resilience Ratio for Eagle Veterinary Technology Co.Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Eagle Veterinary Technology Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.73% | ₩7.18 Billion | ₩61.24 Billion | +1.34pp |
| 2023-12-31 | 10.39% | ₩6.08 Billion | ₩58.48 Billion | +0.57pp |
| 2022-12-31 | 9.82% | ₩5.39 Billion | ₩54.87 Billion | -6.96pp |
| 2021-12-31 | 16.78% | ₩8.83 Billion | ₩52.60 Billion | +3.98pp |
| 2020-12-31 | 12.80% | ₩6.19 Billion | ₩48.41 Billion | +7.56pp |
| 2019-12-31 | 5.23% | ₩2.41 Billion | ₩45.94 Billion | +3.37pp |
| 2018-12-31 | 1.86% | ₩858.96 Million | ₩46.11 Billion | -0.47pp |
| 2017-12-31 | 2.33% | ₩1.16 Billion | ₩49.77 Billion | -3.82pp |
| 2016-12-31 | 6.15% | ₩2.84 Billion | ₩46.18 Billion | +5.43pp |
| 2015-12-31 | 0.73% | ₩320.00 Million | ₩44.00 Billion | +0.18pp |
| 2014-12-31 | 0.55% | ₩230.00 Million | ₩41.66 Billion | -- |